MedPage Today on MSN
Better Survival in Kidney Cancer After Stopping Therapy for Immune-Related AEs
DENVER -- Patients who discontinued treatment for advanced kidney cancer because of immune-related adverse events (irAEs) had ...
MedPage Today on MSN
Drug Holidays for Advanced Kidney Cancer a Consideration for Selected Patients
DENVER -- Planned treatment "holidays" can help lessen the toxicity burden of tyrosine kinase inhibitors (TKIs) for selected ...
At the 2025 International Kidney Cancer Symposium, Dr. Michael Staehler, of the University of Munich, highlighted the ...
The FDA's fast track designation aims to expedite ITM-94's development for diagnosing clear cell renal cell carcinoma. The ...
MedPage Today on MSN
Ivermectin for Kidney Cancer: Patients Have Questions, Clinicians Have Concerns
Interest in ivermectin for kidney cancer has come primarily from preclinical studies. Authors of a review from China stated ...
A specialist in treating kidney cancer patients explained why the rare cancer struck someone at such a young age.
Merrimack residents fear that PFAS contamination is to blame. But with federal dollars in flux, the researchers may not get ...
DPI-4452 targets CAIX in tumors, offering noninvasive diagnostic potential for ccRCC with favorable tolerability. The agent is part of a theranostic pair wi ...
Longtime WVLT sports director Rick Russo is receiving an outpouring of support from friends and viewers after sharing a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback